B Beyer1, H Huland1, M Graefen2. 1. Martini-Klinik am UKE GmbH, Martinistraße 52, 20246, Hamburg, Deutschland. 2. Martini-Klinik am UKE GmbH, Martinistraße 52, 20246, Hamburg, Deutschland. graefen@uke.de.
Abstract
BACKGROUND: Measurement of the quality of treatment has become increasingly important in hospitals. An easy and practical solution in data acquisition is the Patient-Reported Outcome Measurement (PROM). METHODS: In this article the historical development, general conditions, and difficulties of using the outcome measurement in our patients are describe. In addition, we illustrate the wide range of benefits due to our survey. Based on data from 2008-2013, the functional and oncological results of treatment in our clinic are shown. The main focus lies on the PROMs, e.g., urinary continence evaluated with the daily pad use, sexual function with the IIEF-5 questionnaire, and postoperative complications. CONCLUSIONS: A systematic and standardized outcome measurement may help to improve the quality of treatment, provides factual information for patients, and supports medical development.
BACKGROUND: Measurement of the quality of treatment has become increasingly important in hospitals. An easy and practical solution in data acquisition is the Patient-Reported Outcome Measurement (PROM). METHODS: In this article the historical development, general conditions, and difficulties of using the outcome measurement in our patients are describe. In addition, we illustrate the wide range of benefits due to our survey. Based on data from 2008-2013, the functional and oncological results of treatment in our clinic are shown. The main focus lies on the PROMs, e.g., urinary continence evaluated with the daily pad use, sexual function with the IIEF-5 questionnaire, and postoperative complications. CONCLUSIONS: A systematic and standardized outcome measurement may help to improve the quality of treatment, provides factual information for patients, and supports medical development.
Entities:
Keywords:
Erectile dysfunction; Outcome, oncological; Quality of life; Quality of treatment; Urinary incontinence
Authors: Thomas Steuber; Markus Graefen; Alexander Haese; Andreas Erbersdobler; Felix K-H Chun; Thorsten Schlom; Paul Perrotte; Hartwig Huland; Pierre I Karakiewicz Journal: J Urol Date: 2006-03 Impact factor: 7.450
Authors: Thorsten Schlomm; Hans Heinzer; Thomas Steuber; Georg Salomon; Oliver Engel; Uwe Michl; Alexander Haese; Markus Graefen; Hartwig Huland Journal: Eur Urol Date: 2011-03-22 Impact factor: 20.096
Authors: Hendrik Isbarn; Manuela Wanner; Georg Salomon; Thomas Steuber; Thorsten Schlomm; Jens Köllermann; Guido Sauter; Alexander Haese; Hans Heinzer; Hartwig Huland; Markus Graefen Journal: BJU Int Date: 2009-12-11 Impact factor: 5.588
Authors: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Eric Klein; Patrick Kupelian; Donald G Skinner; Gary Lieskovsky; Bernard Bochner; Hartwig Huland; Peter G Hammerer; Alexander Haese; Andreas Erbersdobler; James A Eastham; Jean de Kernion; Thomas Cangiano; Fritz H Schröder; Mark F Wildhagen; Theo H van der Kwast; Peter T Scardino; Michael W Kattan Journal: J Clin Oncol Date: 2002-08-01 Impact factor: 44.544